| Year |
Citation |
Score |
| 2022 |
Lee LW, Shafiani S, Crossley B, Emerson RO, Williamson D, Bunin A, Vargas J, Han AS, Kaplan IM, Green PHR, Kirsch I, Bhagat G. Characterisation of T cell receptor repertoires in coeliac disease. Journal of Clinical Pathology. PMID 36522177 DOI: 10.1136/jcp-2022-208541 |
0.339 |
|
| 2020 |
Tsuji T, Eng KH, Matsuzaki J, Battaglia S, Szender JB, Miliotto A, Gnjatic S, Bshara W, Morrison CD, Lele S, Emerson RO, Wang J, Liu S, Robins H, Lugade AA, et al. Clonality and antigen-specific responses shape the prognostic effects of tumor-infiltrating T cells in ovarian cancer. Oncotarget. 11: 2669-2683. PMID 32676168 DOI: 10.18632/Oncotarget.27666 |
0.508 |
|
| 2020 |
Ching T, Duncan ME, Newman-Eerkes T, McWhorter MME, Tracy JM, Steen MS, Brown RP, Venkatasubbarao S, Akers NK, Vignali M, Moorhead ME, Watson D, Emerson RO, Mann TP, Cimler BM, et al. Analytical evaluation of the clonoSEQ Assay for establishing measurable (minimal) residual disease in acute lymphoblastic leukemia, chronic lymphocytic leukemia, and multiple myeloma. Bmc Cancer. 20: 612. PMID 32605647 DOI: 10.1186/S12885-020-07077-9 |
0.363 |
|
| 2020 |
Reuben A, Zhang J, Chiou SH, Gittelman RM, Li J, Lee WC, Fujimoto J, Behrens C, Liu X, Wang F, Quek K, Wang C, Kheradmand F, Chen R, Chow CW, ... ... Emerson R, et al. Comprehensive T cell repertoire characterization of non-small cell lung cancer. Nature Communications. 11: 603. PMID 32001676 DOI: 10.1038/S41467-019-14273-0 |
0.489 |
|
| 2019 |
Ramien C, Yusko EC, Engler JB, Gamradt S, Patas K, Schweingruber N, Willing A, Rosenkranz SC, Diemert A, Harrison A, Vignali M, Sanders C, Robins HS, Tolosa E, Heesen C, ... ... Emerson RO, et al. T Cell Repertoire Dynamics during Pregnancy in Multiple Sclerosis. Cell Reports. 29: 810-815.e4. PMID 31644905 DOI: 10.1016/J.Celrep.2019.09.025 |
0.429 |
|
| 2019 |
Chu ND, Bi HS, Emerson RO, Sherwood AM, Birnbaum ME, Robins HS, Alm EJ. Longitudinal immunosequencing in healthy people reveals persistent T cell receptors rich in highly public receptors. Bmc Immunology. 20: 19. PMID 31226930 DOI: 10.1186/S12865-019-0300-5 |
0.472 |
|
| 2019 |
Nordstrom JL, Muth J, Erskine CL, Sanders C, Yusko EC, Emerson RO, Lee M, Lee S, Trepel JB, Im S, Bang Y, Giaccone G, Bauer TM, Burris HA, Baughman JE, et al. High frequency of HER2-specific immunity observed in patients (pts) with HER2+ cancers treated with margetuximab (M), an Fc-enhanced anti-HER2 monoclonal antibody (mAb). Journal of Clinical Oncology. 37: 1030-1030. DOI: 10.1200/Jco.2019.37.15_Suppl.1030 |
0.429 |
|
| 2018 |
Formenti SC, Rudqvist NP, Golden E, Cooper B, Wennerberg E, Lhuillier C, Vanpouille-Box C, Friedman K, Ferrari de Andrade L, Wucherpfennig KW, Heguy A, Imai N, Gnjatic S, Emerson RO, Zhou XK, et al. Radiotherapy induces responses of lung cancer to CTLA-4 blockade. Nature Medicine. PMID 30397353 DOI: 10.1038/S41591-018-0232-2 |
0.42 |
|
| 2018 |
Wang J, Rea B, Haun P, Emerson R, Kirsch I, Bagg A. High-Throughput Sequencing of the T-cell receptor beta chain gene distinguishes two subgroups of cutaneous T-cell lymphoma. Journal of the American Academy of Dermatology. PMID 30365996 DOI: 10.1016/J.Jaad.2018.10.027 |
0.467 |
|
| 2018 |
DeWitt WS, Yu KKQ, Wilburn DB, Sherwood A, Vignali M, Day CL, Scriba TJ, Robins HS, Swanson WJ, Emerson RO, Bradley PH, Seshadri C. A Diverse Lipid Antigen-Specific TCR Repertoire Is Clonally Expanded during Active Tuberculosis. Journal of Immunology (Baltimore, Md. : 1950). PMID 29914888 DOI: 10.4049/Jimmunol.1800186 |
0.399 |
|
| 2018 |
Rea B, Haun P, Emerson R, Vignali M, Farooqi M, Samimi S, Elenitsas R, Kirsch I, Bagg A. Role of high-throughput sequencing in the diagnosis of cutaneous T-cell lymphoma. Journal of Clinical Pathology. 71: 814-820. PMID 29636372 DOI: 10.1136/Jclinpath-2018-205004 |
0.432 |
|
| 2018 |
James CA, Yu KKQ, Gilleron M, Prandi J, Yedulla VR, Moleda ZZ, Diamanti E, Khan M, Aggarwal VK, Reijneveld JF, Reinink P, Lenz S, Emerson RO, Scriba TJ, Souter MNT, et al. CD1b Tetramers Identify T Cells that Recognize Natural and Synthetic Diacylated Sulfoglycolipids from Mycobacterium tuberculosis. Cell Chemical Biology. PMID 29398561 DOI: 10.1016/J.Chembiol.2018.01.006 |
0.462 |
|
| 2018 |
Ariyan CE, Brady MS, Siegelbaum RH, Hu J, Bello DM, Green J, Fisher C, Lefkowitz RA, Panageas KS, Pulitzer M, Vignali M, Emerson R, Tipton C, Robins H, Merghoub T, et al. Robust antitumor responses result from local chemotherapy and CTLA-4 blockade. Cancer Immunology Research. PMID 29339377 DOI: 10.1158/2326-6066.Cir-17-0356 |
0.424 |
|
| 2018 |
Plant AS, Koyama S, Sinai C, Solomon IH, Griffin GK, Ligon KL, Bandopadhayay P, Betensky R, Emerson R, Dranoff G, Kieran MW, Ritz J. Immunophenotyping of pediatric brain tumors: correlating immune infiltrate with histology, mutational load, and survival and assessing clonal T cell response. Journal of Neuro-Oncology. PMID 29322427 DOI: 10.1007/S11060-017-2737-9 |
0.331 |
|
| 2017 |
Rudqvist NP, Pilones KA, Lhuillier C, Wennerberg E, Sidhom JW, Emerson RO, Robins HS, Schneck J, Formenti SC, Demaria S. Radiotherapy and CTLA-4 blockade shape the TCR repertoire of tumor-infiltrating T cells. Cancer Immunology Research. PMID 29180535 DOI: 10.1158/2326-6066.Cir-17-0134 |
0.512 |
|
| 2017 |
Park CO, Fu X, Jiang X, Pan Y, Teague JE, Collins N, Tian T, O'Malley JT, Emerson RO, Kim JH, Jung Y, Watanabe R, Fuhlbrigge RC, Carbone FR, Gebhardt T, et al. Staged development of long lived TCRαβ Th17 resident memory T cell population to Candida albicans after skin infection. The Journal of Allergy and Clinical Immunology. PMID 29128674 DOI: 10.1016/J.Jaci.2017.09.042 |
0.317 |
|
| 2017 |
Reuben A, Gittelman RM, Gao J, Zhang J, Yusko E, Wu CJ, Emerson R, Zhang J, Tipton CM, Li J, Quek K, Gopalakrishnan V, Chen R, Vence L, Cascone T, et al. TCR Repertoire Intratumor Heterogeneity in Localized Lung Adenocarcinomas: an Association with Predicted Neoantigen Heterogeneity and Postsurgical Recurrence. Cancer Discovery. PMID 28733428 DOI: 10.1158/2159-8290.Cd-17-0256 |
0.49 |
|
| 2017 |
Brunner PM, Emerson RO, Tipton C, Garcet S, Khattri S, Coats I, Krueger JG, Guttman-Yassky E. Non-lesional atopic dermatitis skin shares similar T-cell clones with lesional tissues. Allergy. PMID 28599078 DOI: 10.1111/All.13223 |
0.338 |
|
| 2017 |
Dovedi SJ, Cheadle EJ, Popple A, Poon E, Morrow M, Stewart R, Yusko E, Sanders C, Vignali M, Emerson R, Robins H, Wilkinson RW, Honeychurch J, Illidge T. Fractionated radiation therapy stimulates anti-tumor immunity mediated by both resident and infiltrating polyclonal T-cell populations when combined with PD1 blockade. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 28533222 DOI: 10.1158/1078-0432.Ccr-16-1673 |
0.489 |
|
| 2017 |
Lavin Y, Kobayashi S, Leader A, Amir ED, Elefant N, Bigenwald C, Remark R, Sweeney R, Becker CD, Levine JH, Meinhof K, Chow A, Kim-Shulze S, Wolf A, Medaglia C, ... ... Emerson RO, et al. Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses. Cell. 169: 750-765.e17. PMID 28475900 DOI: 10.1016/J.Cell.2017.04.014 |
0.416 |
|
| 2017 |
Pollack SM, He Q, Yearley JH, Emerson R, Vignali M, Zhang Y, Redman MW, Baker KK, Cooper S, Donahue B, Loggers ET, Cranmer LD, Spraker MB, Seo YD, Pillarisetty VG, et al. T-cell infiltration and clonality correlate with programmed cell death protein 1 and programmed death-ligand 1 expression in patients with soft tissue sarcomas. Cancer. PMID 28463396 DOI: 10.1002/Cncr.30726 |
0.337 |
|
| 2017 |
Emerson RO, DeWitt WS, Vignali M, Gravley J, Hu JK, Osborne EJ, Desmarais C, Klinger M, Carlson CS, Hansen JA, Rieder M, Robins HS. Immunosequencing identifies signatures of cytomegalovirus exposure history and HLA-mediated effects on the T cell repertoire. Nature Genetics. PMID 28369038 DOI: 10.1038/Ng.3822 |
0.454 |
|
| 2017 |
Chapuis AG, Desmarais C, Emerson R, Schmitt TM, Shibuya K, Lai I, Wagener F, Chou J, Roberts IM, Coffey DG, Warren E, Robbins H, Greenberg PD, Yee C. Tracking the Fate and Origin of Clinically Relevant Adoptively Transferred CD8(+) T Cells In Vivo. Science Immunology. 2. PMID 28367538 DOI: 10.1126/Sciimmunol.Aal2568 |
0.485 |
|
| 2017 |
Pollack S, He Q, Yearley J, Emerson RO, Vignali M, Zhang Y, Redman M, Loggers ET, Cranmer LD, Pillarisetty VG, Ricciotti R, Hoch BL, Murphy E, McClanahan TK, Blumenschein W, et al. Correlation of T-cell infiltration and clonality with PD-L1 expression in soft tissue sarcomas. Journal of Clinical Oncology. 35: 23-23. DOI: 10.1200/Jco.2017.35.7_Suppl.23 |
0.452 |
|
| 2017 |
Maoz A, Greenson JK, Melas M, Emerson RO, Vignali M, Robins H, Qu C, Schmit S, Pinchev M, McDonnell KJ, Rennert G, Gruber SB. Similar T-cell repertoires of tumor infiltrating lymphocytes and Crohn’s-like lymphoid reaction in colorectal cancer. Journal of Clinical Oncology. 35: e15133-e15133. DOI: 10.1200/Jco.2017.35.15_Suppl.E15133 |
0.51 |
|
| 2017 |
Reuben A, Gittelman R, Zhang J, Yusko E, Wu C, Emerson RO, Zhang J, Tipton C, Vignali M, Fujimoto J, Rodriguez-Canales J, Swisher S, Heymach J, Robins H, Lee JJ, et al. TCR repertoire sequencing of 254 resected non-small cell lung cancers to reveal TCR clonality in normal tissues compared to tumor tissues. Journal of Clinical Oncology. 35: 11500-11500. DOI: 10.1200/Jco.2017.35.15_Suppl.11500 |
0.484 |
|
| 2017 |
Plant A, Koyama S, Sinai C, Solomon I, Griffin G, Betensky R, Emerson R, Dranoff G, Kieran M, Ritz J. IMMU-04. IMMUNOPHENOTYPING OF PEDIATRIC BRAIN TUMORS: CORRELATING IMMUNE INFILTRATE WITH HISTOLOGY, MUTATIONAL LOAD, AND SURVIVAL AND ASSESSING CLONAL T CELL RESPONSE Neuro-Oncology. 19: vi113-vi113. DOI: 10.1093/Neuonc/Nox168.463 |
0.407 |
|
| 2017 |
Plant AS, Koyama S, Sinai C, Solomon I, Griffin G, Betensky R, Emerson R, Dranoff G, Kieran MW, Ritz J. IMMU-23. IMMUNOPHENOTYPING OF PEDIATRIC BRAIN TUMORS: CORRELATING IMMUNE INFILTRATE WITH HISTOLOGY, MUTATIONAL LOAD, AND SURVIVAL AND ASSESSING CLONAL T CELL RESPONSE Neuro-Oncology. 19: iv32-iv32. DOI: 10.1093/Neuonc/Nox083.133 |
0.439 |
|
| 2016 |
Faham M, Carlton V, Moorhead M, Zheng J, Klinger M, Pepin F, Asbury T, Vignali M, Emerson RO, Robins HS, Ireland J, Baechler-Gillespie E, Inman RD. Discovery of T-Cell Receptor Beta Motifs Specific to HLA-B27(+) Ankylosing Spondylitis by Deep Repertoire Sequence Analysis. Arthritis & Rheumatology (Hoboken, N.J.). PMID 28002888 DOI: 10.1002/Art.40028 |
0.386 |
|
| 2016 |
Seay HR, Yusko E, Rothweiler SJ, Zhang L, Posgai AL, Campbell-Thompson M, Vignali M, Emerson RO, Kaddis JS, Ko D, Nakayama M, Smith MJ, Cambier JC, Pugliese A, Atkinson MA, et al. Tissue distribution and clonal diversity of the T and B cell repertoire in type 1 diabetes. Jci Insight. 1: e88242. PMID 27942583 DOI: 10.1172/Jci.Insight.88242 |
0.429 |
|
| 2016 |
Subudhi SK, Aparicio A, Gao J, Zurita AJ, Araujo JC, Logothetis CJ, Tahir SA, Korivi BR, Slack RS, Vence L, Emerson RO, Yusko E, Vignali M, Robins HS, Sun J, et al. Clonal expansion of CD8 T cells in the systemic circulation precedes development of ipilimumab-induced toxicities. Proceedings of the National Academy of Sciences of the United States of America. PMID 27698113 DOI: 10.1073/Pnas.1611421113 |
0.492 |
|
| 2016 |
Page DB, Yuan J, Redmond D, Wen YH, Durack JC, Emerson R, Solomon SB, Dong Z, Wong P, Comstock C, Diab A, Sung J, Maybody M, Morris EA, Brogi E, et al. Deep Sequencing of T-Cell Receptor DNA as a biomarker of clonally expanded TILs in breast cancer after immunotherapy. Cancer Immunology Research. PMID 27587469 DOI: 10.1158/2326-6066.Cir-16-0013 |
0.498 |
|
| 2016 |
DeWitt WS, Lindau P, Snyder TM, Sherwood AM, Vignali M, Carlson CS, Greenberg PD, Duerkopp N, Emerson RO, Robins HS. A Public Database of Memory and Naive B-Cell Receptor Sequences. Plos One. 11: e0160853. PMID 27513338 DOI: 10.1371/Journal.Pone.0160853 |
0.368 |
|
| 2016 |
Wolf KJ, Emerson RO, Pingel J, Buller RM, DiPaolo RJ. Conventional and Regulatory CD4+ T Cells That Share Identical TCRs Are Derived from Common Clones. Plos One. 11: e0153705. PMID 27100298 DOI: 10.1371/Journal.Pone.0153705 |
0.459 |
|
| 2016 |
Hsu M, Sedighim S, Wang T, Antonios JP, Everson RG, Tucker AM, Du L, Emerson R, Yusko E, Sanders C, Robins H, Yong WH, Davidson TB, Li G, Liau LM, et al. TCR sequencing can identify and track glioma-infiltrating T cells after DC vaccination. Cancer Immunology Research. PMID 26968205 DOI: 10.1158/2326-6066.Cir-15-0240 |
0.494 |
|
| 2016 |
Odunsi K, Tsuji T, Eng KH, Szender JB, Matsuzaki J, Miliotto A, Gnjatic S, Bshara W, Omilian A, Morrison CD, Lele SB, Emerson RO, Desmarais C, Wang J, Liu S, et al. Prognostic effects of peripheral and tumor-infiltrating T-cell repertoire diversity in ovarian cancer. Journal of Clinical Oncology. 34: 5546-5546. DOI: 10.1200/Jco.2016.34.15_Suppl.5546 |
0.417 |
|
| 2016 |
Sedighim S, Hsu M, Wang T, Everson RG, Tucker A, Antonios JP, Du L, Emerson R, Yusko E, Sanders C, Robins H, Yong W, Davidson TB, Li G, Liau LM, et al. Abstract 767: TCR sequencing can identify and track tumor-specific T cell populations and is a predictive biomarker of response to DC vaccination in glioblastoma patients Cancer Research. 76: 767-767. DOI: 10.1158/1538-7445.Am2016-767 |
0.493 |
|
| 2016 |
Hussein M, Wilks S, Monte M, Richards DA, Goldschmidt JH, Waterhouse D, Wang L, Pant S, Yusko E, Emerson RO, Taverna DM, Desai K, Mousses S, Qi Z, Hipp JD, et al. Abstract 4159: Characterization of the T-cell receptor (TCR) repertoire in extensive disease small cell lung cancer (ED SCLC) Cancer Research. 76: 4159-4159. DOI: 10.1158/1538-7445.Am2016-4159 |
0.489 |
|
| 2016 |
Subudhi SK, Aparicio A, Gao J, Zurita-Saavedra A, Araujo JC, Logothetis CJ, Brinda KR, Allison JP, Vence L, Emerson RO, Yusko E, Vignali M, Robins HS, Sun J, Sharma P. Abstract 1402: Exploratory biomarkers that predict for clinical outcomes in a Phase II trial with ipilimumab plus finite androgen deprivation therapy for metastatic non-castrate prostate cancer Cancer Research. 76: 1402-1402. DOI: 10.1158/1538-7445.Am2016-1402 |
0.348 |
|
| 2016 |
Salit RB, Emerson R, Karanes C, Gutman JA, Nikiforow S, Duncan C, Kurtzberg J, Robins H, Rieder M, Delaney C. Interim Analysis of an Observational Study Assessing T Cell Receptor Diversity As an Early Predictor of NRM in Cord Blood Transplant Recipients Biology of Blood and Marrow Transplantation. 22: S44. DOI: 10.1016/J.Bbmt.2015.11.326 |
0.382 |
|
| 2015 |
Rawstron AC, Fazi C, Agathangelidis A, Villamor N, Letestu R, Nomdedeu J, Palacio C, Stehlikova O, Kreuzer KA, Liptrot S, O'Brien D, de Tute RM, Marinov I, Hauwel M, Spacek M, ... ... Emerson R, et al. A complementary role of multiparameter flow-cytometry and high-throughput sequencing for minimal residual disease (MRD) detection in chronic lymphocytic leukemia (CLL): An european research initiative on CLL (ERIC) study. Leukemia. PMID 26639181 DOI: 10.1038/Leu.2015.313 |
0.314 |
|
| 2015 |
Dean J, Emerson RO, Vignali M, Sherwood AM, Rieder MJ, Carlson CS, Robins HS. Annotation of pseudogenic gene segments by massively parallel sequencing of rearranged lymphocyte receptor loci. Genome Medicine. 7: 123. PMID 26596423 DOI: 10.1186/S13073-015-0238-Z |
0.398 |
|
| 2015 |
Howie B, Sherwood AM, Berkebile AD, Berka J, Emerson RO, Williamson DW, Kirsch I, Vignali M, Rieder MJ, Carlson CS, Robins HS. High-throughput pairing of T cell receptor α and β sequences. Science Translational Medicine. 7: 301ra131. PMID 26290413 DOI: 10.1126/Scitranslmed.Aac5624 |
0.459 |
|
| 2015 |
Robert L, Tsoi J, Wang X, Emerson R, Homet B, Chodon T, Mok S, Huang RR, Cochran AJ, Comin-Anduix B, Koya RC, Graeber TG, Robins H, Ribas A. Erratum: CTLA4 blockade broadens the peripheral T-cell receptor repertoire (Clinical Cancer Research (2014) 20 (2424-2432)) Clinical Cancer Research. 21. PMID 26180060 DOI: 10.1158/1078-0432.Ccr-15-1088 |
0.41 |
|
| 2015 |
Thapa DR, Tonikian R, Sun C, Liu M, Dearth A, Petri M, Pepin F, Emerson RO, Ranger A. Longitudinal analysis of peripheral blood T cell receptor diversity in patients with systemic lupus erythematosus by next-generation sequencing. Arthritis Research & Therapy. 17: 132. PMID 26001779 DOI: 10.1186/S13075-015-0655-9 |
0.353 |
|
| 2015 |
Gaide O, Emerson RO, Jiang X, Gulati N, Nizza S, Desmarais C, Robins H, Krueger JG, Clark RA, Kupper TS. Common clonal origin of central and resident memory T cells following skin immunization. Nature Medicine. 21: 647-53. PMID 25962122 DOI: 10.1038/Nm.3860 |
0.473 |
|
| 2015 |
DeWitt WS, Emerson RO, Lindau P, Vignali M, Snyder TM, Desmarais C, Sanders C, Utsugi H, Warren EH, McElrath J, Makar KW, Wald A, Robins HS. Dynamics of the cytotoxic T cell response to a model of acute viral infection. Journal of Virology. 89: 4517-26. PMID 25653453 DOI: 10.1128/Jvi.03474-14 |
0.454 |
|
| 2015 |
Munhoz RR, Merghoub T, Emerson RO, Callahan MK, Wolchok JD, Postow MA. Investigation of intrapatient heterogeneity in the tumor infiltrating T cell repertoire in patients with metastatic melanoma treated with pembrolizumab. Journal of Clinical Oncology. 33: 9075-9075. DOI: 10.1200/Jco.2015.33.15_Suppl.9075 |
0.4 |
|
| 2015 |
Page DB, Wen YH, Brogi E, Yuan J, Emerson RO, Patil S, Dang CT, Norton L, Hudis CA, McArthur HL. Characterization of dominant T-cell clones by T-cell receptor (TCR) deep sequencing as a potential predictive biomarker to neoadjuvant trastuzumab (tras) in HER2-positive (HER2+) breast cancer. Journal of Clinical Oncology. 33: 609-609. DOI: 10.1200/Jco.2015.33.15_Suppl.609 |
0.455 |
|
| 2015 |
Zaretsky JM, Blum SM, Robert Faja L, Emerson RO, Ribas A. TCR use and cytokine response in PD-1 blockade. Journal of Clinical Oncology. 33: 3027-3027. DOI: 10.1200/Jco.2015.33.15_Suppl.3027 |
0.398 |
|
| 2015 |
Pilones KA, Emerson R, Formenti SC, Robbins HS, Demaria S. Mechanisms of synergy of radiotherapy and immunotherapy Journal of Translational Medicine. 13: K5. DOI: 10.1186/1479-5876-13-S1-K5 |
0.468 |
|
| 2015 |
Orlowski R, Huang A, Gohil M, Mangan J, Vignali M, Emerson RO, Robins H, Yusko E, Jordan MS, Carroll M, Gilliland DG, Hexner EO. Integrated Immunological Analysis of the Bone Marrow Tumor Microenvironment in Myeloproliferative Neoplasms to Determine Potential Efficacy of Immune Checkpoint Blockade Blood. 126: 2766-2766. DOI: 10.1182/Blood.V126.23.2766.2766 |
0.417 |
|
| 2015 |
Page D, Yuan J, Diab A, Dong Z, Ginsberg A, Wong P, Emerson R, Redmond D, Blum B, Mu Z, Zhao C, Comstock C, Morris E, Comen E, Kotin A, et al. Abstract P2-15-01: Integrated immunologic assessment of tumor infiltrating lymphocytes (TILs) and peripheral blood to assess synergy of cryoablation (cryo) plus ipilimumab (ipi) in early stage breast cancer (ESBC) patients (pts) Cancer Research. 75. DOI: 10.1158/1538-7445.Sabcs14-P2-15-01 |
0.494 |
|
| 2015 |
Pilones K, Koelwyn G, Emerson R, Formenti S, Robins H, Demaria S. Abstract 2856: Unique changes in the TCR repertoire of tumor-infiltrating lymphocytes underlie the synergy of radiotherapy with CTLA-4 blockade Cancer Research. 75: 2856-2856. DOI: 10.1158/1538-7445.Am2015-2856 |
0.499 |
|
| 2015 |
Sedighim S, Hsu M, Antonios J, Emerson R, Yusko E, Sanders C, Davidson T, Liau L, Prins R. IMCT-11NEXT GENERATION T CELL RECEPTOR SEQUENCING CAN IDENTIFY, QUANTIFY, AND TRACK TUMOR-SPECIFIC T CELL POPULATIONS BEFORE AND AFTER DENDRITIC CELL VACCINATION IN GLIOBLASTOMA MULTIFORME PATIENTS Neuro-Oncology. 17: v109.4-v110. DOI: 10.1093/Neuonc/Nov218.11 |
0.447 |
|
| 2014 |
Yuan J, Ginsberg A, Dong Z, Wong P, Emerson R, Sung JS, Comstock C, Solomon SB, Sacchini V, Morrow M, Brogi E, Morris EA, Patil S, Robins H, Wolchok JD, et al. Tumor and systemic immune responses to preoperative (pre-op) cryoablation (cryo) plus immune therapy with ipilimumab (ipi) in early-stage breast cancer (ESBC). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 64. PMID 28141090 DOI: 10.1200/Jco.2014.32.26_Suppl.64 |
0.411 |
|
| 2014 |
Dudgeon C, Chan C, Kang W, Sun Y, Emerson R, Robins H, Levine AJ. The evolution of thymic lymphomas in p53 knockout mice. Genes & Development. 28: 2613-20. PMID 25452272 DOI: 10.1101/Gad.252148.114 |
0.439 |
|
| 2014 |
Tumeh PC, Harview CL, Yearley JH, Shintaku IP, Taylor EJ, Robert L, Chmielowski B, Spasic M, Henry G, Ciobanu V, West AN, Carmona M, Kivork C, Seja E, Cherry G, ... ... Emerson RO, et al. PD-1 blockade induces responses by inhibiting adaptive immune resistance. Nature. 515: 568-71. PMID 25428505 DOI: 10.1038/Nature13954 |
0.354 |
|
| 2014 |
Emerson RO, Mathew JM, Konieczna IM, Robins HS, Leventhal JR. Defining the alloreactive T cell repertoire using high-throughput sequencing of mixed lymphocyte reaction culture. Plos One. 9: e111943. PMID 25365040 DOI: 10.1371/Journal.Pone.0111943 |
0.481 |
|
| 2014 |
Robert L, Harview C, Emerson R, Wang X, Mok S, Homet B, Comin-Anduix B, Koya RC, Robins H, Tumeh PC, Ribas A. Distinct immunological mechanisms of CTLA-4 and PD-1 blockade revealed by analyzing TCR usage in blood lymphocytes. Oncoimmunology. 3: e29244. PMID 25083336 DOI: 10.4161/Onci.29244 |
0.448 |
|
| 2014 |
Wu D, Emerson RO, Sherwood A, Loh ML, Angiolillo A, Howie B, Vogt J, Rieder M, Kirsch I, Carlson C, Williamson D, Wood BL, Robins H. Detection of minimal residual disease in B lymphoblastic leukemia by high-throughput sequencing of IGH. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 4540-8. PMID 24970842 DOI: 10.1158/1078-0432.Ccr-13-3231 |
0.32 |
|
| 2014 |
Robert L, Tsoi J, Wang X, Emerson R, Homet B, Chodon T, Mok S, Huang RR, Cochran AJ, Comin-Anduix B, Koya RC, Graeber TG, Robins H, Ribas A. CTLA4 blockade broadens the peripheral T-cell receptor repertoire Clinical Cancer Research. 20: 2424-2432. PMID 24583799 DOI: 10.1158/1078-0432.Ccr-13-2648 |
0.429 |
|
| 2014 |
Robert L, Harview C, Emerson R, Wang X, Mok S, Homet B, Comin-Anduix B, Koya RC, Robins H, Tumeh PC, Ribas A. Distinct immunological mechanisms of CTLA-4 and PD-1 blockade revealed by analyzing TCR usage in blood lymphocytes Oncoimmunology. 3. DOI: 10.4161/onci.29244 |
0.349 |
|
| 2014 |
Page DB, Diab A, Yuan J, Dong Z, Emerson R, Robins H, Redmond D, Zhao C, Mu Z, Wong P, Solomon SB, Sacchini V, Morrow M, Brogi E, Patil S, et al. T-cell receptor (TCR) DNA deep sequencing to evaluate clonality of tumor-infiltrating lymphocytes (TILs) in early-stage breast cancer patients (pts) receiving preoperative cryoablation (cryo) and/or ipilimumab (ipi). Journal of Clinical Oncology. 32: 3021-3021. DOI: 10.1200/Jco.2014.32.15_Suppl.3021 |
0.448 |
|
| 2014 |
Pilones K, Emerson R, Formenti S, Robins H, Demaria S. Unique changes in the TCR repertoire of tumor-infiltrating lymphocytes underlie the synergy of radiotherapy with CTLA-4 blockade Journal For Immunotherapy of Cancer. 2. DOI: 10.1186/2051-1426-2-S3-P141 |
0.354 |
|
| 2014 |
Page DB, McArthur H, Dong Z, Wong P, Emerson R, Mu Z, Zhao C, Comstock C, Morris E, Comen E, Kotin A, Sung J, Brogi E, Morrow M, Solomon S, et al. Matched T cell repertoire analysis of peripheral blood and tumor-infiltrating lymphocytes (TILs) in early stage breast cancer (ESBC) patients (pts) treated with pre-operative cryoablation (cryo) and/or Ipilimumab (Ipi) Journal For Immunotherapy of Cancer. 2. DOI: 10.1186/2051-1426-2-S3-P138 |
0.456 |
|
| 2014 |
Emerson RO, Nikiforow S, Milano F, Sherwood AM, Papermaster A, Guthrie KA, Carlson CS, Warren EH, Ritz J, Robins H, Cutler CS, Delaney C. TCR Repertoire Diversity Assessed with Immunosequencing Is Associated with Patient Mortality Following Cord Blood Transplant Blood. 124: 1262-1262. DOI: 10.1182/Blood.V124.21.1262.1262 |
0.409 |
|
| 2014 |
Robert L, Harview CL, Emerson R, Mok S, Homet B, Comin-Anduix B, Koya RC, Robins H, Tumeh PC, Ribas A. Abstract 5015: TCR usage analysis in blood reveals different mechanisms of action of CTLA-4 and PD-1 blockade in patients Cancer Research. 74: 5015-5015. DOI: 10.1158/1538-7445.Am2014-5015 |
0.419 |
|
| 2014 |
Sherwood AM, Robins H, Fromm JR, Greisman HA, Sabath DE, Emerson RO, Rieder M, Wood B, Wu D. Abstract 1895: Identifying clonal T-cell receptor sequences and monitoring recurrent/persistent disease by T-cell receptor repertoire profiling in patients with mature T-cell neoplasms Cancer Research. 74: 1895-1895. DOI: 10.1158/1538-7445.Am2014-1895 |
0.501 |
|
| 2014 |
Nikiforow S, Kim HT, McDonough SM, Emerson R, Hamm D, Ballen KK, Boussiotis VA, Soiffer RJ, Antin JH, Ritz J, Cutler CS. Recipient T-Cell Repertoire Diversity after Double Umbilical Cord Transplantation Correlates with Non-Relapse Mortality and Survival Biology of Blood and Marrow Transplantation. 20: S243-S244. DOI: 10.1016/J.Bbmt.2013.12.409 |
0.352 |
|
| 2013 |
Carlson CS, Emerson RO, Sherwood AM, Desmarais C, Chung MW, Parsons JM, Steen MS, LaMadrid-Herrmannsfeldt MA, Williamson DW, Livingston RJ, Wu D, Wood BL, Rieder MJ, Robins H. Using synthetic templates to design an unbiased multiplex PCR assay. Nature Communications. 4: 2680. PMID 24157944 DOI: 10.1038/Ncomms3680 |
0.431 |
|
| 2013 |
Emerson RO, Sherwood AM, Rieder MJ, Guenthoer J, Williamson DW, Carlson CS, Drescher CW, Tewari M, Bielas JH, Robins HS. High-throughput sequencing of T-cell receptors reveals a homogeneous repertoire of tumour-infiltrating lymphocytes in ovarian cancer. The Journal of Pathology. 231: 433-40. PMID 24027095 DOI: 10.1002/Path.4260 |
0.515 |
|
| 2013 |
Sherwood AM, Emerson RO, Scherer D, Habermann N, Buck K, Staffa J, Desmarais C, Halama N, Jaeger D, Schirmacher P, Herpel E, Kloor M, Ulrich A, Schneider M, Ulrich CM, et al. Tumor-infiltrating lymphocytes in colorectal tumors display a diversity of T cell receptor sequences that differ from the T cells in adjacent mucosal tissue. Cancer Immunology, Immunotherapy : Cii. 62: 1453-61. PMID 23771160 DOI: 10.1007/S00262-013-1446-2 |
0.494 |
|
| 2013 |
Emerson R, Sherwood A, Desmarais C, Malhotra S, Phippard D, Robins H. Estimating the ratio of CD4+ to CD8+ T cells using high-throughput sequence data Journal of Immunological Methods. 391: 14-21. PMID 23428915 DOI: 10.1016/J.Jim.2013.02.002 |
0.463 |
|
| 2013 |
Tsuji T, Eng KH, Gnjatic S, Matsuzaki J, Brightwell R, Miliotto A, Emerson R, Desmarais C, Lindsley E, Rubinstein J, Wang J, Liu S, Robins H, Odunsi K. Tumor-infiltrating T lymphocyte clonality predicts prognosis in human ovarian cancer Journal For Immunotherapy of Cancer. 1. DOI: 10.1186/2051-1426-1-S1-P64 |
0.54 |
|
| 2013 |
Rieder MJ, Williamson D, Sherwood A, Emerson RO, Desmarais C, Chung M, Robins H, Carlson CS. Frequency Of Gene Usage and Copy Number Variation Within The Rearranged Immunoglobin Heavy-Chain Variable Locus Based On Immune Repertoire Sequencing Blood. 122: 3486-3486. DOI: 10.1182/Blood.V122.21.3486.3486 |
0.367 |
|
| 2013 |
Sherwood A, Robins H, Fromm JR, Greisman HA, Sabath DE, Emerson RO, Rieder MJ, Wood BL, Wu D. Detection Of Recurrent/Persistent Disease By T-Cell Receptor Repertoire Profiling In Patients With Mature T-Cell Neoplasm Blood. 122: 2614-2614. DOI: 10.1182/Blood.V122.21.2614.2614 |
0.486 |
|
| 2013 |
Wu D, Emerson RO, Sherwood A, Loh ML, Angiolillo A, Kirsch I, Carlson CS, Williamson D, Wood BL, Robins H. Robust Detection Of Minimal Residual Disease In Unselected Patients With B-Cell Precursor Acute Lymphoblastic Leukemia By High-Throughput Sequencing Of IGH Blood. 122: 2550-2550. DOI: 10.1182/Blood.V122.21.2550.2550 |
0.331 |
|
| 2013 |
Wu D, Emerson RO, Sherwood A, Loh ML, Angiolillo A, Kirsch I, Carlson CS, Williamson D, Wood BL, Robins H. On-Going Evolution Of IGH In B-Cell Precursor Acute Lymphoblastic Leukemia Does Not Substantially Affect Day 29, Post-Treatment MRD Quantification By High-Throughput Sequencing Blood. 122: 1341-1341. DOI: 10.1182/Blood.V122.21.1341.1341 |
0.358 |
|
| 2013 |
DeWitt WS, Lindau P, Emerson RO, Sherwood A, Williamson D, Rieder MJ, Chung M, Carlson CS, Robins H. Assessing B Lymphocyte Clonal Diversity, Expansion, and Convergent Evolution By High-Throughput Sequencing Of Rearranged IGH Segments From Naïve and Memory Repertoires Blood. 122: 1045-1045. DOI: 10.1182/Blood.V122.21.1045.1045 |
0.387 |
|
| 2013 |
Delaney C, Emerson R, Milano F, Sherwood A, Papermaster A, Guthrie KA, Carlson C, Warren EH, Robins H. Evolution and Clinical Implications of the T Cell Repertoire Following Cord Blood Transplant Biology of Blood and Marrow Transplantation. 19: S201-S202. DOI: 10.1016/J.Bbmt.2012.11.220 |
0.387 |
|
| 2012 |
Delaney C, Emerson RO, Milano F, Sherwood A, Papermaster A, Guthrie KA, Carlson CS, Warren EH, Robins H. T Cell Repertoire Diversity After Umbilical Cord Transplant Predicts Mortality From Infection Blood. 120: 4202-4202. DOI: 10.1182/Blood.V120.21.4202.4202 |
0.487 |
|
| 2011 |
Emerson RO, Thomas JH. Gypsy and the birth of the SCAN domain. Journal of Virology. 85: 12043-52. PMID 21865395 DOI: 10.1128/Jvi.00867-11 |
0.442 |
|
| 2009 |
Thomas JH, Emerson RO, Shendure J. Extraordinary molecular evolution in the PRDM9 fertility gene. Plos One. 4: e8505. PMID 20041164 DOI: 10.1371/Journal.Pone.0008505 |
0.458 |
|
| 2009 |
Thomas JH, Emerson RO. Evolution of C2H2-zinc finger genes revisited. Bmc Evolutionary Biology. 9: 51. PMID 19261184 DOI: 10.1186/1471-2148-9-51 |
0.456 |
|
| 2009 |
Emerson RO, Thomas JH. Adaptive evolution in zinc finger transcription factors. Plos Genetics. 5: e1000325. PMID 19119423 DOI: 10.1371/Journal.Pgen.1000325 |
0.439 |
|
| Show low-probability matches. |